Epilepsy treatment by sacrificing vitamin D

References

• Bhalla D, Godet B, Druet-Cabanac M, Preux PM. Etiologies of epilepsy: a comprehensive review. Expert Rev Neurother 2011;11(6):861-76
   PubMed Web of Science ®Google Scholar
• Geerts A, Arts WF, Stroink H, et al. Course and outcome of childhood epilepsy: a 15-year follow-up of the Dutch Study of Epilepsy in Childhood. Epilepsia 2010;51(7):1189-97
   PubMed Web of Science ®Google Scholar
• Sillanpää M, Schmidt D. Predicting antiepileptic drug response in children with epilepsy. Expert Rev Neurother 2011;11(6):877-85
   PubMed Web of Science ®Google Scholar
• Aronson E, Stevenson SB. Bone health in children with cerebral palsy and epilepsy. J Pediatr Health Care 2012;26(3):193-9
   PubMed Web of Science ®Google Scholar
• Sellier E, Uldall P, Calado E, et al. Epilepsy and cerebral palsy: characteristics and trends in children born in 1976-1998. Eur J Paediatr Neurol 2012;16(1):48-55
   PubMed Web of Science ®Google Scholar
• Misra M, Pacaud D, Petryk A, et al. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008;122(2):398-417
   PubMed Web of Science ®Google Scholar
• Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011;364(3):248-54
   PubMed Web of Science ®Google Scholar
• Wagner CL, Greer FR. A merican Academy of Pediatrics Section on Breastfeeding; American Academy of Pediatrics Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122(5):1142-52
   PubMed Web of Science ®Google Scholar
• Norris JM. Can the sunshine vitamin shed light on type 1 diabetes? Lancet 2001;358(9292):1476-8
   PubMed Web of Science ®Google Scholar
• Sakaki T, Kagawa N, Yamamoto K, Inouye K. Metabolism of vitamin D3 by cytochromes P450. Front Biosci 2005;10:119-34
   PubMed Web of Science ®Google Scholar
• Fraser DR. Vitamin D. Lancet 1995;345(8942):104-7
   PubMed Web of Science ®Google Scholar
• Braegger C, Campoy C, Colomb V, et al. ESPGHAN Committee on Nutrition. Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr 2013;56(6):692-701
   PubMed Web of Science ®Google Scholar
• Hamed SA. Influences of bone and mineral metabolism in epilepsy. Expert Opin Drug Saf 2011;10(2):265-80
   PubMed Web of Science ®Google Scholar
• Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006;47(3):510-15
   PubMed Web of Science ®Google Scholar
• DeLuca HF. Evolution of our understanding of vitamin D. Nutr Rev 2008;66(10 Suppl 2):73-87
   PubMed Web of Science ®Google Scholar
• Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am 2010;39(2):255-69
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys 2012;523(1):123-33
   PubMed Web of Science ®Google Scholar
• Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29(6):726-76
   PubMed Web of Science ®Google Scholar
• Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116(8):2062-72
   PubMed Web of Science ®Google Scholar
• Wang Z, Lin YS, Zheng XE, et al. An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. Mol Pharmacol 2012;81(4):498-509
   PubMed Web of Science ®Google Scholar
• Zhou C, Assem M, Tay JC, et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006;116(6):1703-12
   PubMed Web of Science ®Google Scholar
• Wrzosek M, Łukaszkiewicz J, Wrzosek M, et al. Vitamin D and the central nervous system. Pharmacol Rep 2013;65(2):271-8
   PubMed Web of Science ®Google Scholar
• Brown J, Bianco JI, McGrath JJ, Eyles DW. 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003;343(2):139-43
   PubMed Web of Science ®Google Scholar
• Burkert R, McGrath J, Eyles D. Vitamin D receptor expression in the embryonic rat brain. Neurosci Res Commun 2003;33(1):63-71
   Google Scholar
• Eyles D, Burne T, McGrath J. Vitamin D in fetal brain development. Semin Cell Dev Biol 2011;22(6):629-36
   PubMed Web of Science ®Google Scholar
• Garcion E, Thanh XD, Bled F, et al. 1,25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brain. Neurosci Lett 1996;216(3):183-6
   PubMed Web of Science ®Google Scholar
• Harms LR, Eyles DW, McGrath JJ, et al. Developmental vitamin D deficiency alters adult behaviour in 129/SvJ and C57BL/6J mice. Behav Brain Res 2008;187(2):343-50
   PubMed Web of Science ®Google Scholar
• McGrath JJ, Eyles DW, Pedersen CB, et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case–control study. Arch Gen Psychiatry 2010;67(9):889-94
   PubMed Web of Science ®Google Scholar
• McGrath J, Saari K, Hakko H, et al. Vitamin D supplementation during the first year of lifeand risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004;67(2-3):237-45
   PubMed Web of Science ®Google Scholar
• Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 2008;194(1-2):7-17
   PubMed Web of Science ®Google Scholar
• Lefebvre d’Hellencourt C, Montero-Menei CN, Bernard R, Couez D. Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line. J Neurosci Res 2003;71(4):575-82
   PubMed Web of Science ®Google Scholar
• Christiansen C, Rodbro P, Sjö O. Anticonvulsant action of vitamin D in epileptic patients? A controlled pilot study. Br Med J 1974;2(5913):258-9
   PubMedGoogle Scholar
• Kalueff AV, Minasyan A, Keisala T, et al. Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene. Neurosci Lett 2006;394(1):69-73
   PubMed Web of Science ®Google Scholar
• Kalueff AV, Minasyan A, Tuohimaa P. Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res Bull 2005;67(1–2):156-60
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009;19(2):73-8
   PubMed Web of Science ®Google Scholar
• Snellman G, Melhus H, Gedeborg R, et al. Determining vitamin D status: a comparison between commercially available assays. PLoS One 2010;5(7):e11555
   PubMed Web of Science ®Google Scholar
• Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7(5):439-43
   PubMed Web of Science ®Google Scholar
• Seamans KM, Cashman KD. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 2009;89(6):1997S-2008S
   Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004;116(9):634-9
   PubMed Web of Science ®Google Scholar
• Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;22(2):142-6
   PubMed Web of Science ®Google Scholar
• Thacher TD, Fischer PR, Pettifor JM, et al. Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr 2000;46(3):132-9
   PubMed Web of Science ®Google Scholar
• Vieth R, Ladak Y, Walfish PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 2003;88(1):185-91
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010;21(7):1151-4
   PubMed Web of Science ®Google Scholar
• Mithal A, Wahl DA, Bonjour JP, et al. IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009;20(11):1807-20
   PubMed Web of Science ®Google Scholar
• Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol 2013;S0960-0760(13):00233-1
   Google Scholar
• Kumar J, Muntner P, Kaskel FJ, et al. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics 2009;124(3):e362-70
   Web of Science ®Google Scholar
• Ahmed SF, Franey C, McDevitt H, et al. Recent trends and clinical features of childhood vitamin D deficiency presenting to a children’s hospital in Glasgow. Arch Dis Child 2011;96(7):694-6
   PubMed Web of Science ®Google Scholar
• Beck-Nielsen SS, Jensen TK, Gram J, et al. Nutritional rickets in Denmark: a retrospective review of children’s medical records from 1985 to 2005. Eur J Pediatr 2009;168(8):941-9
   PubMed Web of Science ®Google Scholar
• Lapatsanis D, Moulas A, Cholevas V, et al. Vitamin D: a necessity for children and adolescents in Greece. Calcif Tissue Int 2005;77(6):348-55
   PubMed Web of Science ®Google Scholar
• Akman AO, Tumer L, Hasanoglu A, et al. Frequency of vitamin D insufficiency in healthy children between 1 and 16 years of age in Turkey. Pediatr Int 2011;53(6):968-73
   PubMed Web of Science ®Google Scholar
• Rodriguez-Rodriguez E, Aparicio A, Lopez-Sobaler AM, et al. Vitamin D status in a group of Spanish school children. Minerva Pediatr 2011;63(1):11-18
   PubMed Web of Science ®Google Scholar
• Offermann G, Pinto V, Kruse R. Antiepileptic drugs and vitamin D supplementation. Epilepsia 1979;20(1):3-15
   PubMed Web of Science ®Google Scholar
• Nettekoven S, Ströhle A, Trunz B, et al. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr 2008;167(12):1369-77
   PubMed Web of Science ®Google Scholar
• Shellhaas RA, Barks AK, Joshi SM. Prevalence and risk factors for vitamin D insufficiency among children with epilepsy. Pediatr Neurol 2010;42(6):422-6
   PubMed Web of Science ®Google Scholar
• Misra A, Aggarwal A, Singh O, Sharma S. Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children. Pediatr Neurol 2010;43(5):320-4
   PubMed Web of Science ®Google Scholar
• Aksoy A, Sönmez FM, Deger O, et al. The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy. J Pediatr Endocrinol Metab 2011;24(9-10):703-8
   PubMed Web of Science ®Google Scholar
• Borusiak P, Langer T, Heruth M, et al. Antiepileptic drugs and bone metabolism in children: data from 128 patients. J Child Neurol 2013;28(2):176-83
   PubMed Web of Science ®Google Scholar
• Rieger-Wettengl G, Tutlewski B, Stabrey A, et al. Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine. Pediatrics 2001;108(6):E107
   PubMed Web of Science ®Google Scholar
• Verrotti A, Greco R, Latini G, et al. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 2002;43(12):1488-92
   PubMed Web of Science ®Google Scholar
• El-Hajj Fuleihan G, Dib L, Yamout B, et al. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone 2008;43(1):149-55
   PubMed Web of Science ®Google Scholar
• Fong CY, Riney CJ, Vitamin D. Deficiency Among Children With Epilepsy in South Queensland. J Child Neurol 2014;29(3):368-73.
   PubMed Web of Science ®Google Scholar
• Nicolaidou P, Georgouli H, Kotsalis H, et al. Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol 2006;21(3):205-9
   PubMed Web of Science ®Google Scholar
• Pack AM. Treatment of epilepsy to optimize bone health. Curr Treat Options Neurol 2011;13(4):346-54
   PubMed Web of Science ®Google Scholar
• Volpe SL, Schall JI, Gallagher PR, et al. Nutrient intake of children with intractable epilepsy compared with healthy children. J Am Diet Assoc 2007;107(6):1014-18; 64
   PubMedGoogle Scholar
• Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008;57(2):183-91
   PubMed Web of Science ®Google Scholar
• Lagunova Z, Porojinicu AC, Lindberg FA, et al. Vitamin D status in Norwegian children and adolescents with excess body weight. Pediatr Diabetes 2011;12(2):120-6
   PubMed Web of Science ®Google Scholar
• Daniels ZS, Nick TG, Liu C, et al. Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy. Neurology 2009;73(9):658-64
   PubMed Web of Science ®Google Scholar
• Bergqvist AG, Schall JI, Stallings VA. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia 2007;48(1):66-71
   PubMed Web of Science ®Google Scholar
• Baer MT, Kozlowski BW, Blyler EM, et al. Vitamin D,calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status. Am J Clin Nutr 1997;65(4):1042-51
   PubMed Web of Science ®Google Scholar
• Turner Z, Kossoff EH. The ketogenic and Atkins diet: recipes for seizure control. Pract Gastroenterol 2006;30:53-64
   Google Scholar
• Bergqvist AG, Schall JI, Stallings VA, Zemel BS. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr 2008;88(6):1678-84
   PubMed Web of Science ®Google Scholar
• Shellhaas RA, Joshi SM. Vitamin D and bone health among children with epilepsy. Pediatr Neurol 2010;42(6):385-93
   PubMed Web of Science ®Google Scholar
• Zhou C, Assem M, Tay JC, et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006;116(6):1703-12
   PubMed Web of Science ®Google Scholar
• Kitanaka S, Isojima T, Takaki M, et al. Association of vitamin D-related gene polymorphisms with manifestation of vitamin D deficiency in children. Endocr J 2012;59(11):1007-14
   PubMed Web of Science ®Google Scholar
• Liu YZ, Liu YJ, Recker RR, Deng HW. Molecular studies of identification of genes for osteoporosis: the 2002 update. J Endocrinol 2003;177(2):147-96
   PubMed Web of Science ®Google Scholar
• Lambrinoudaki I, Kaparos G, Armeni E, et al. BsmI vitamin D receptor’s polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy. Eur J Neurol 2011;18(1):93-8
   PubMed Web of Science ®Google Scholar
• Phabphal K, Geater A, Limapichart K, et al. The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin. Epilepsia 2013;54(2):249-55
   PubMed Web of Science ®Google Scholar
• Peterson P, Gray P, Tolman KG. Calcium balance in drug-induced osteomalacia: response to vitamin D. Clin Pharmacol Ther 1976;19(1):63-7
   PubMed Web of Science ®Google Scholar
• Oner N, Kaya M, Karasalihoğlu S, et al. Bone mineral metabolism changes in epileptic children receiving valproic acid. J Paediatr Child Health 2004;40(8):470-3
   PubMed Web of Science ®Google Scholar
• Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol 2006;35(3):177-81
   PubMed Web of Science ®Google Scholar
• Verrotti A, Agostinelli S, Coppola G, et al. 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy. Eur J Neurol 2010;17(2):232-7
   PubMed Web of Science ®Google Scholar
• Tekgul H, Serdaroglu G, Huseyinov A, Gökben S. Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy. J Child Neurol 2006;21(5):411-14
   PubMed Web of Science ®Google Scholar
• Erbayat Altay E, Serdaroğlu A, Tümer L, et al. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab 2000;13(7):933-9
   PubMed Web of Science ®Google Scholar
• Wu S, Legido A, De Luca F. Effects of valproic acid on longitudinal bone growth. J Child Neurol 2004;19(1):26-30
   PubMed Web of Science ®Google Scholar
• Guo CY, Ronen GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 2001;42(9):1141-7
   PubMed Web of Science ®Google Scholar
• Cansu A, Yesilkaya E, Serdaroğlu A, et al. Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol 2008;39(4):266-71
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ, Marcus R, et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 2005;57(2):252-7
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ, McMahon DJ, Shane E. Normal vitamin D and low free estradiol levels in women on enzyme –inducing antiepileptic drugs. Epilepsy Behav 2011;21(4):453-8
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JW, Choi KG, et al. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav 2007;10(2):291-5
   PubMed Web of Science ®Google Scholar
• Rauchenzauner M, Griesmacher A, Tatarczyk T, et al. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Dev Med Child Neurol 2010;52(3):283-8
   PubMed Web of Science ®Google Scholar
• Disthabanchong S, Radinahamed P, Stitchantrakul W, et al. Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells. Kidney Int 2007;71(3):201-9
   PubMed Web of Science ®Google Scholar
• Ward KA, Das G, Berry JL, et al. Vitamin D status and muscle function in post-menarchal adolescent girls. J Clin Endocrinol Metab 2009;94(2):559-63
   PubMed Web of Science ®Google Scholar
• Tang J, Chonchol MB. Vitamin D and kidney stone disease. Curr Opin Nephrol Hypertens 2013;22(4):383-9
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Pyzik PL, Furth SL, et al. Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002;43(10):1168-71
   PubMed Web of Science ®Google Scholar